HR 2335 · 114th Congress 2015–2017, ended

Stop Tampering of Prescription Pills Act of 2015

Latest action · May 15, 2015 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 14, 2015
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Stop Tampering of Prescription Pills Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to deny approval to a new oral opioid (a drug with effects similar to opium, such as morphine) that does not have properties that make the drug significantly more difficult to abuse if an abuse-deterrent drug containing the same opioid is available. The FDA may approve an opioid drug that is not abuse-deterrent if approval is necessary to prevent or alleviate a drug shortage or to address a significant unmet public health need.

To be approved by the FDA, a generic version of an abuse-deterrent brand name drug must be at least comparably abuse-deterrent and its active components must not differ in any material respect from the brand name drug.

An approved generic drug is not bioequivalent to, and does not have the same therapeutic effect as, a brand name drug that becomes abuse-deterrent unless the generic drug is at least comparably abuse-deterrent.

Approval of a generic oral opioid is withdrawn if the brand name drug is not abuse-deterrent and not available and there is an approved abuse-deterrent drug available that contains the same opioid in the same dose.

Approval of an oral opioid is withdrawn if the drug is not abuse-deterrent and there is an approved abuse-deterrent drug available that contains the same opioid. Withdrawal of approval may be waived by the FDA for a drug intended for a special needs population. The FDA must delay withdrawal to give the drug sponsor an opportunity to obtain approval for an abuse-deterrent formulation of the drug.

Cosponsors 9

Members who signed on, in the order they did. Signatures ran from May 14, 2015 to Jul 8, 2015; 8 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-KYHarold RogersOriginalMay 14, 2015
D-MAJames P. McGovernOriginalMay 14, 2015
D-ILJanice D. SchakowskyOriginalMay 14, 2015
D-MAJoseph P. Kennedy IIIOriginalMay 14, 2015
R-ALRobert B. AderholtOriginalMay 14, 2015
D-MAStephen F. LynchOriginalMay 14, 2015
R-FLThomas J. RooneyOriginalMay 14, 2015
R-FLVern BuchananOriginalMay 14, 2015
D-MAKatherine M. ClarkJul 8, 2015

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 14, 2015
Health Subcommittee
Referred May 15, 2015

Actions 3

Everything that happened, newest first.

  1. May 15, 2015Referred to the Subcommittee on Health.
  2. May 14, 2015Introduced in House
  3. May 14, 2015Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H2201Sheila Jackson Lee D-TXMay 10, 2016

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8 of the United States Constitution.

The sponsor’s statement, as printed in the Congressional Record, vol. 161, no. 74, May 14, 2015, page H3213.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to incentivize the development of abuse-deterrent drugs.
Short Titles as Introduced
Stop Tampering of Prescription Pills Act of 2015

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 14, 2015Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.